Shalini Sharp
DirectoratNeurocrine Biosciences· In proxies 2022–2025
Shalini Sharp sits on 16 public boards.
Boards1
- Neurocrine BiosciencesDirector · 5 yr on the boardIndependentAudit (Chair), Compensation—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- Neurocrine BiosciencesPublic company · 4 yr
- Director2022 – Present · 4 yrStock in role +72%
- BeOne Medicines Ltd.Public company
- Director? – PresentNo stock prices for these years
- BeiGene, Ltd.Public company
- Director? – PresentNo stock prices for these years
- Directors for Mahzi TherapeuticsPublic company
- Director? – PresentNo stock prices for these years
- Iambic Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Mirati Therapeutics, Sutro BiopharmaPublic company
- Director? – PresentNo stock prices for these years
- Organon & CoPublic company
- Director? – PresentNo stock prices for these years
- Septerna, Inc.Public company
- Director? – PresentNo stock prices for these years
- Array BiopharmaPublic company
- Director? – PresentNo stock prices for these years
- BiosciencesPublic company
- Director? – PresentNo stock prices for these years
- Mirati TherapeuticsPublic company
- Director? – PresentNo stock prices for these years
- Nuvation BioPublic company
- Director? – PresentNo stock prices for these years
- Panacea Acquisition Corp.Public company
- Director? – PresentNo stock prices for these years
- Precision BioSciences, Inc.Public company
- Director? – PresentNo stock prices for these years
- Sutro Biopharma, Inc.Public company
- Director? – PresentNo stock prices for these years
- TB AlliancePublic company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?